Assessing preparedness for Alzheimer disease-modifying therapies in Australasian health care systems

Med J Aust. 2023 Apr 3;218(6):247-249. doi: 10.5694/mja2.51880. Epub 2023 Mar 19.

Authors

Amy Brodtmann^{1

2}, David Darby¹, Carly Oboudiyat³, Colin J Mahoney⁴, Campbell Le Heron⁵, Peter K Panegyres⁶, Bruce Brew⁷

Affiliations

¹ Monash University, Melbourne, VIC.
² Florey Institute of Neuroscience and Mental Health, Melbourne, VIC.
³ Royal North Shore Hospital, Sydney, NSW.
⁴ Brain and Mind Centre, University of Sydney, Sydney, NSW.
⁵ New Zealand Brain Research Institute, Christchurch, New Zealand.
⁶ Neurodegenerative Disorders Research, Perth, WA.
⁷ University of New South Wales, Sydney, NSW.

PMID: 36934371
DOI: 10.5694/mja2.51880

No abstract available

Keywords: Alzheimer disease; Dementia; Health personnel; Magnetic resonance imaging; Medical colleges; Neurodegenerative disorders.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Alzheimer Disease* / therapy
Brain
Delivery of Health Care
Humans
Magnetic Resonance Imaging

Associated data

ClinicalTrials.gov/NCT04437511
ClinicalTrials.gov/NCT04388254
ClinicalTrials.gov/NCT04592874